Value-Based Oncology at Scale: Inside Thyme Care

Cancer care in the U.S. costs over $250 billion each year, and nearly 2 million Americans receive a new diagnosis annually, yet too often the journey begins with silence: no call, no plan, no guide. In this episode, a16z’s Vineeta Agarwala and Jay Rughani talk with Thyme Care leaders Robin Shah (cofounder and CEO), Bobby Green, MD (president and CMO), and Brad Diephuis, MD (president and COO) about rebuilding oncology around the patient. They cover where the system breaks, how navigation plus value-based contracts align incentives, how AI can extend clinicians, and what scale looks like today, more than 83,000 active patients. A concise blueprint for truly patient-centered cancer care. Timecodes: 0:00 Introduction 1:47 Personal Stories & Early Days of Time Care 5:27 Building the Team & Mission 7:07 The Patient Journey: Where the System Fails 9:58 Why Tech Hasn’t Solved Cancer Care (Yet) 15:45 Scaling Impact: Growth & Partnerships 17:45 How Time Care Works: Value-Based Care Explained 23:15 Technology, AI, and the Human Touch 37:06 Building for the Future: Generational Impact Resources: Find Robin on LinkedIn: https://www.linkedin.com/in/robin-shah-8072bb35 Find Bobby on LinkedIn: https://www.linkedin.com/in/drbobbygreen/ FInd Brad on LinkedIn: https://www.linkedin.com/in/bdiephuis/ Find Vineeta on X: https://x.com/vintweeta Find Jay on X: https://x.com/JayRughani Stay Updated: If you enjoyed this episode, be sure to like, subscribe, and share with your friends! a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company.